104960-23-8 Usage
Type
Sterol derivative
Biosynthetic Pathway
Intermediate in cholesterol biosynthesis
Production
Enzymatic conversion of lanosterol
Role
Key in regulating and controlling cholesterol production in cells
Therapeutic Potential
Investigated as a target for managing cholesterol levels
Research Implications
Potential for developing treatments for cholesterol-related diseases
Diseases
Atherosclerosis, familial hypercholesterolemia
Importance
Crucial in cholesterol biosynthetic pathway
Therapeutic Strategies
Potential for developing new strategies to manage cholesterol levels
Check Digit Verification of cas no
The CAS Registry Mumber 104960-23-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,4,9,6 and 0 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 104960-23:
(8*1)+(7*0)+(6*4)+(5*9)+(4*6)+(3*0)+(2*2)+(1*3)=108
108 % 10 = 8
So 104960-23-8 is a valid CAS Registry Number.
InChI:InChI=1/C30H51NO/c1-19(9-12-24-27(4,5)31-24)20-13-17-30(8)22-10-11-23-26(2,3)25(32)15-16-28(23,6)21(22)14-18-29(20,30)7/h19-20,23-25,31-32H,9-18H2,1-8H3/t19-,20-,23+,24?,25+,28-,29-,30+/m1/s1
104960-23-8Relevant articles and documents
SYNTHESIS OF NEW EPIMINOISOPENTENOIDS
Parish, Edward J.,Nes, W. David
, p. 221 - 226 (2007/10/02)
Treatment of the isopentenoids geraniol, farnesol, and lanosterol with an excess of iodine azide and lithium aluminium hydride results in the selective introduction of the aziridine function at the terminal and least hindered isopentenoid unit.Treatment of squalene in an analogous manner resulted in the formation of diepiminosqualene.
